AmpliSeq for Illumina Comprehensive Cancer Panel
AmpliSeq for Illumina Comprehensive Cancer Panel
The AmpliSeq for Illumina Comprehensive Cancer Panel provides a targeted resequencing solution for analyzing somatic mutations across 409 genes with known associations. The Comprehensive Cancer panel is part of a streamlined workflow that includes PCR-based library preparation, Illumina sequencing by synthesis (SBS) chemistry and next-generation sequencing (NGS) technology, and automated analysis. It requires as little as 1 ng high quality DNA or 10 ng from DNA from low-quality samples per pool, making it compatible with various sample types, including formalin-fixed, paraffin-embedded (FFPE) tissues to multiple cancer types, including lung, colon, breast, ovarian, melanoma, and prostate.
- Panel:
- 20019160 AmpliSeq for Illumina Comprehensive Cancer Panel, 24 Reactions
- Library Prep:
- 20019101 AmpliSeq for Illumina Library PLUS, 24 Reactions
- 20019102 AmpliSeq for Illumina Library PLUS, 96 Reactions
- 20019103 AmpliSeq for Illumina Library PLUS, 384 Reactions
- Indexes:
- 20019105 AmpliSeq for Illumina CD Indexes Set A, 96 Indexes, 96 Reactions
| Species Compatibility | Human | |
|---|---|---|
| Recommended Illumina Instrument* | NextSeq | |
| Recommended Samples per run† | Mid Output | High Output |
| 4 | 12 | |
| Max Recommended Read Length | 2×150 | |
| Recommended Secondary Analysis | DNA Amplicon App, DNA Amplicon Module | |
| Recommended Down Stream Analysis | Variant Interpreter | |
* Library prep is compatible with all Illumina instruments. Recommended instruments chosen based on typical output and analysis need for selected application.
† Assumes minimum coverage of 500×
Please rotate your device for details
